This inventor holds 1 USPTO granted patent. Top assignee: The Cleveland Clinic Foundation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Matthew R. Porter: Inventor of a SARS-CoV-2 Protease Inhibitor Patent
Introduction
Matthew R. Porter is an inventor associated with Cleveland, Ohio, and The Cleveland Clinic Foundation. His patent work concerns compounds designed to inhibit a key protease of SARS-CoV-2.
Latest Patents
Porter is named on 1 patent, titled “Protease Inhibitors and Methods of Use.” The patent describes compounds that inhibit the 3C-like protease of SARS-CoV-2, along with pharmaceutical compositions containing those compounds. It also outlines methods for using them to treat viral infections, including coronavirus infections.
Career Highlights
Porter’s listed patent connects his work with research into potential therapeutic approaches to coronavirus infection. The patent identifies The Cleveland Clinic Foundation as the organization with which he is associated.
Collaborations
Porter’s named coworkers include Shaun R. Stauffer and Jonathan D. Macdonald. Their inclusion reflects a collaborative research effort behind the patent.
Conclusion
Matthew R. Porter’s patent activity highlights his contribution to research on compounds intended to inhibit SARS-CoV-2 protease and support potential treatments for coronavirus infection.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile